Cheng-Han Lee

14PUBLICATIONS
196CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Dec 22, 2025
GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT.

Cheng-Han Lee, Yow-Shan Lee, Jennifer A Bennett

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Sep 19, 2025
A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma.

Astrid De Boeck, Eun Young Kang, Nicola S Meagher

|Aug 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

Pageof 3

Frequent Collaborators

11 joint publications

Martin Koebel

5 joint publications

Nicola S Meagher

4 joint publications

Sian Fereday

3 joint publications

Gregg S Nelson